Navigation Links
Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker

CHICAGO--(BUSINESS WIRE)--Jun 4, 2007 - Introgen Therapeutics, Inc. (NASDAQ: INGN) and the Company's clinical collaborators today reported updated Phase 2 data demonstrating a significant correlation between abnormal p53, tumor responses and increased survival following ADVEXIN(R) therapy in patients with recurrent squamous cell carcinoma of the head and neck. The data (Abstract #6057) were presented today at the annual meeting of the American Society of Clinical Oncology in Chicago.

Tumor responses were assessed in 112 patients with recurrent head and neck cancer who received ADVEXIN. Overall, the percentages of patients with tumor responses defined by reductions in bi-dimensional tumor area on CT scan of 50 percent, 25 percent, 10 percent or stable disease for more than 2 treatment cycles were 6 percent, 7 percent, 12 percent and 22 percent, respectively. Median survival for these responder populations were 41, 17, 15 and 10 months, respectively. There was a statistically significant increase in median survival for each of the responder populations compared to the 6 month median survival of the non-responders (p less than 0.0016).

"The 41 month median duration of survival for the patients with a 50 percent or greater reduction in tumor size is very impressive and significantly greater than the six month median survival of non-responders that is typical for patients with recurrent tumors," said John Nemunaitis, M.D., Medical Director, Mary Crowley Medical Research Center. "Our findings are also consistent with a growing body of data that even smaller reductions in tumor size are clinically meaningful and are associated with increased survival."

The presentation also included data demonstrating that the predictive abnormal p53 biomarker was associated with a statistically significant increase in tumor responses to ADVEXIN therapy. A reduction in tumor size was observed in 40 percent of patients wi
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Introgen Reports Promising Phase 1/2 Clinical Results With INGN 241 in Patients With Advanced Solid Tumors
2. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer
3. Introgen and Clinical Collaborators to Report New Results with Advanced-Stage Cancer Therapies at Upcoming Medical Meetings
4. Preclinical Studies Identify Novel Approach for Enhancing the Anticancer Activity of Introgens INGN 241
5. Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference
6. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
7. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
10. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
11. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
Post Your Comments:
(Date:3/2/2015)... , March 2, 2015  Maquet Medical ... that it has signed an exclusive distribution agreement ... Medical,s flagship product, the Flight 60 mechanical ventilator. ... technology, providing dependable and affordable mobility. Starting in ... will be sold in the United ...
(Date:3/2/2015)... LITTLE FALLS, N.J. , March 2, 2015 /PRNewswire/ ... today that Andrew A. Krakauer , CEO, will ... Emerging Growth Institutional Investor Forum. The formal presentation is ... 2015 at the Grand Hyatt Hotel, New ... Seth Yellin , Senior VP-Corporate Development, will be available ...
(Date:3/2/2015)... the past 15 years, there has been an average of over ... Census Bureau 2012). Of course, not every accident is severe and ... a few where the car occupants can get stuck in their ... button or occupant injury. One may be lucky ... but may still be "lucky" enough to come upon an auto ...
Breaking Medicine Technology:Maquet Medical Systems USA to Exclusively Distribute Flight Medical's Flight 60 Respiratory Ventilators 2Maquet Medical Systems USA to Exclusively Distribute Flight Medical's Flight 60 Respiratory Ventilators 3New SuperVizor, an Automobile Escape Tool, Ensures the Safety of Drivers and Passengers on the Road 2
(Date:3/2/2015)... Calvary Hospital recently honored Peter ... in Lutheran Medical Center, with the DAISY Award. ... excellence through clinical expertise as well as extraordinary, ... above and beyond to make a difference and ... their families. Award recipients are chosen by co-workers, ...
(Date:3/2/2015)... Cutler Integrative Medicine a leader in bringing innovative ... tips to bring about self-renewal. A 30 day detox ... first cleaning house. According to Dr. Cutler, expert ... Between environmental toxins like heavy metals, people’s food now ... stress levels, we all have a level of toxic ...
(Date:3/2/2015)... A cocaine snorting Oscar statue in Hollywood is ... or scathing scuffle. A new take on the glamour ... Hollywood as Paper Jesus’ rendition of the venerable Oscar ... in Hollywood. The Oscar statue is depicted snorting cocaine, ... the travails of drug addiction in Hollywood. Paper Jesus, ...
(Date:3/2/2015)... March 02, 2015 While many hospitals ... VI of the Civil Rights Act, the unique needs ... loss are bringing light to the value of video ... that nearly 1 in 20 U.S. children have LEP—a ... in some major cities.(1) Stratus Video Interpreting ...
(Date:3/2/2015)... Robins & Morton Celebrates Women In Construction ... Construction Week (March 1-7, sponsored by the National Association ... History Month, Robins & Morton is recognizing several women ... the construction industry as a whole. From the craft ... roles in between, each woman has a story to ...
Breaking Medicine News(10 mins):Health News:Calvary Hospital Honors Peter Acerios, RN, with Daisy Award 2Health News:Skin and Wellness Power Couple give Quick Tips to Self-Renewal for Spring 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 2Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 4Health News:Robins & Morton Recognizes Women In Construction 2
... International, scientists evaluating new drug targets against tuberculosis (TB) ... could rapidly eliminate infections and potentially shorten treatment time. ... gyrase B, found in bacteria that cause TB infections. ... subunits: gyrase A and gyrase B. Although gyrase A ...
... 29 (HealthDay News) -- Nearly 40 percent of American seniors ... at least one prescription drug that is potentially unsafe or ... rate is nearly three times higher than for seniors who ... leader Dr. Yuhua Bao, an assistant professor of public health ...
... clinics between 1997 and 2008, opioid prescriptions for chronic ... study in Clinical Gastroenterology and Hepatology , the ... abdominal pain is a common symptom and a frequent ... clinicians often find it challenging to help their patients ...
... have in the decision-making, thought-processing part of your brain, the ... seem like an obvious conclusion, but a new study conducted ... the first to show this link between structure and function ... and function in people addicted to cocaine. The study appears ...
... discuss preclinical drug discovery and development at SUNY Downstate ... will take place at 12:00 noon in the Health ... Road, Brooklyn, New York 11203. Dr. Clark,s ... modified to become "Lead" compounds in the high-risk drug ...
... N.H. Runners over the age of 60 are the fastest-growing ... New Hampshire suggests that their running can remain fast as they ... Strength and Conditioning Research , found that the running economy ... of older runners was no different than that of younger runners. ...
Cached Medicine News:Health News:Medication Review May Benefit Home Health Care Patients 2Health News:Gray matter in brain's control center linked to ability to process reward 2Health News:Gray matter in brain's control center linked to ability to process reward 3Health News:Dr. Luther T. Clark to present Merck Academy Talk at SUNY Downstate 2Health News:Study: No decline in running economy for older runners 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: